RNA vs SWKS · rev $22.6M vs P/E 29, rev $4.09B
Atrium Therapeutics, Inc. Common Stock (RNA) versus Skyworks Solutions Inc (SWKS) — a side-by-side from cached financials, not a winner call.
Atrium Therapeutics, Inc. Common Stock (RNA) is a biotechnology company listed on NASDAQ.
Skyworks Solutions Inc (SWKS) is a semiconductors company listed on NASDAQ.
Latest reported RNA revenue for 2026-06-30 was $22.6M. Net income was -$36.8M. Revenue was up 15.3% from 2026-03-31 to 2026-06-30. RNA currently screens at market cap $217.5M.
Latest reported SWKS revenue for 2025-10-03 was $4.09B. Net income was $477.1M. SWKS currently screens at market cap $10.44B and trailing P/E 28.9.
RNA currently screens at market cap $217.5M. SWKS currently screens at market cap $10.44B and trailing P/E 28.9.
Not investment advice. Open the RNA and SWKS stock pages for the full models.
Not investment advice.